Kovitz Investment Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.4M Sell
40,494
-150
-0.4% -$8.64K 0.15% 54
2015
Q3
$2.21M Sell
40,644
-758
-2% -$49.3K 0.13% 52
2015
Q2
$2.78M Sell
41,402
-300
-0.7% -$19.6K 0.15% 54
2015
Q1
$2.44M Sell
41,702
-570
-1% -$34.4K 0.13% 54
2014
Q4
$2.77M Sell
42,272
-2,265
-5% -$143K 0.14% 53
2014
Q3
$2.57M Sell
44,537
-750
-2% -$41.6K 0.13% 50
2014
Q2
$2.56M Sell
45,287
-45,895
-50% -$2.41M 0.13% 54
2014
Q1
$4.17M Buy
91,182
+2,755
+3% +$139K 0.21% 50
2013
Q4
$4.67M Buy
88,427
+42,685
+93% +$2.1M 0.21% 42
2013
Q3
$2.05M Sell
45,742
-45,240
-50% -$2.01M 0.1% 58
2013
Q2
$3.76M Buy
+90,982
New +$3.98M 0.19% 45

Other funds holding ABBV

Kovitz Investment Group's ABBV Position: Q4 2015 in Review

Kovitz Investment Group reduced its AbbVie (ABBV) stake by 0.37% in Q4 2015, selling an estimated $8.64K and leaving 40,494 shares worth $2.4M. The position accounts for 0.15% of the portfolio, ranked #54.

Kovitz Investment Group first reported a position in ABBV in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.67M in Q4 2013. 1,635 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

  • Kovitz Investment Group held 40,494 shares of AbbVie worth $2.4M as of Q4 2015.
  • Kovitz Investment Group sold 150 AbbVie shares in Q4 2015, an estimated $8.64K.
  • AbbVie made up 0.15% of Kovitz Investment Group's portfolio in Q4 2015, its #54 holding.
  • Kovitz Investment Group first reported a position in AbbVie in Q2 2013 and has held it in 11 quarters since.
  • Kovitz Investment Group's AbbVie position peaked at $4.67M in Q4 2013.
  • 1,635 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Kovitz Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.